Model of parkinson s disease. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Substantia Nigra Lewy Bodies Dopaminergic Neurons Subthalamic Nucleus Putamen Neurons Pedunculopontine Tegmental Nucleus Brain Corpus Striatum Globus Pallidus Mesencephalon Mitochondria

Diseases20

Crohn Disease Parkinson Disease Parkinsonian Disorders Parkinson Disease, Secondary Multiple System Atrophy Lewy Body Disease Neurodegenerative Diseases MPTP Poisoning Gait Disorders, Neurologic Supranuclear Palsy, Progressive Essential Tremor REM Sleep Behavior Disorder Gaucher Disease Nerve Degeneration Hypokinesia Dementia Movement Disorders Genetic Predisposition to Disease Dyskinesias Olfaction Disorders

Chemicals and Drugs17

alpha-Synuclein Antiparkinson Agents Levodopa Glucosylceramidase Dopamine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Oxidopamine Ubiquitin-Protein Ligases Oncogene Proteins Tyrosine 3-Monooxygenase Pergolide Carbidopa beta-Synuclein Maneb Neuroprotective Agents 1-Methyl-4-phenylpyridinium Synucleins

Analytical, Diagnostic and Therapeutic Techniques and Equipment5

Duodenoscopy Deep Brain Stimulation Dance Therapy Gait Severity of Illness Index

Psychiatry and Psychology5

Lewy Body Disease Dance Therapy REM Sleep Behavior Disorder Dementia Neuropsychological Tests

Phenomena and Processes4

Postural Balance Gait Genetic Predisposition to Disease Mutation

Health Care2

Age of Onset Severity of Illness Index

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Health Care

Duodenoscopy Crohn Disease Parkinson Disease alpha-Synuclein Antiparkinson Agents Parkinsonian Disorders Parkinson Disease, Secondary Levodopa Glucosylceramidase Substantia Nigra Lewy Bodies Deep Brain Stimulation Multiple System Atrophy Dopamine 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Dopaminergic Neurons Oxidopamine Subthalamic Nucleus Lewy Body Disease Neurodegenerative Diseases MPTP Poisoning Gait Disorders, Neurologic Supranuclear Palsy, Progressive Postural Balance Dance Therapy Putamen Essential Tremor Ubiquitin-Protein Ligases Neurons Pedunculopontine Tegmental Nucleus Brain REM Sleep Behavior Disorder Oncogene Proteins Gaucher Disease Tyrosine 3-Monooxygenase Pergolide Gait Carbidopa Nerve Degeneration beta-Synuclein Hypokinesia Corpus Striatum Dementia Globus Pallidus Movement Disorders Mesencephalon Genetic Predisposition to Disease Age of Onset Mutation Maneb Neuroprotective Agents Mitochondria Dyskinesias 1-Methyl-4-phenylpyridinium Severity of Illness Index Olfaction Disorders Neuropsychological Tests Synucleins

No FAQ available that match "model of parkinson s disease"